News APP

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  gplay

This article was first published 13 years ago
Rediff.com  » Business » Sun Pharma gets nod to sell anti-anxiety drug in US

Sun Pharma gets nod to sell anti-anxiety drug in US

Source: PTI
June 18, 2010 13:53 IST
Get Rediff News in your Inbox:

Sun Pharmaceutical Industries on Friday said that it has received the US Food and Drug Administration's nod to market a generic version of alprazolam, an anti-anxiety drug, in the US market.

The company has received the USFDA's nod for marketing generic alprazolam tablets in four strengths -- 0.25 mg, 0.55 mg, 1 mg and 2 mg -- in the US market, Sun Pharma said in a statement.

Generic alprazolam tablets are equivalent to Pfizer's patented Xanax tablets. Alprazolam has annual sales of $145 million in the United States.

On Thursday, the company had received the US health regulator's nod for marketing a generic version of the Keppra injection, used for treating epilepsy, in the American market. The annual sales estimation for Levetiracetam injections in the US is $85 million, the company said.

Shares of Sun Pharma were trading at Rs 1,695 in the late afternoon trade on BSE, down 0.37 per cent from its previous close.

Get Rediff News in your Inbox:
Source: PTI© Copyright 2024 PTI. All rights reserved. Republication or redistribution of PTI content, including by framing or similar means, is expressly prohibited without the prior written consent.
 

Moneywiz Live!